1921
Volume 97, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

The differential diagnosis for lymphadenopathy is wide and clinical presentations overlap, making obtaining an accurate diagnosis challenging. We sought to characterize the clinical and radiological characteristics, histological findings, and diagnoses for a cohort of patients with lymphadenopathy of unknown etiology. 121 Peruvian adults with lymphadenopathy underwent lymph node biopsy for microbiological and histopathological evaluation. Mean patient age was 41 years (Interquartile Range 26–52), 56% were males, and 39% were HIV positive. Patients reported fever (31%), weight loss (23%), and headache (22%); HIV infection was associated with fever ( < 0.05) and gastrointestinal symptoms ( < 0.05). Abnormalities were reported in 40% of chest X-rays ( = 101). Physicians suspected TB in 92 patients (76%), lymphoma in 19 patients (16%), and other malignancy in seven patients (5.8%). Histological diagnoses ( = 117) included tuberculosis (34%), hyperplasia (27%), lymphoma (13%), and nonlymphoma malignancy (14%). Hyperplasia was more common ( < 0.001) and lymphoma less common ( = 0.005) among HIV-positive than HIV-negative patients. There was a trend toward reduced frequency of caseous necrosis in samples from HIV-positive than HIV-negative TB patients (67 versus 93%, = 0.055). The spectrum of diagnoses was broad, and clinical and radiological features correlated poorly with diagnosis. On the basis of clinical features, physicians over-diagnosed TB, and under-diagnosed malignancy. Although this may not be inappropriate in resource-limited settings where TB is the most frequent easily treatable cause of lymphadenopathy, diagnostic delays can be detrimental to patients with malignancy. It is important that patients with lymphadenopathy undergo a full diagnostic work-up including sampling for histological evaluation to obtain an accurate diagnosis.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.16-0961
2017-10-11
2017-11-21
Loading full text...

Full text loading...

/deliver/fulltext/14761645/97/4/tpmd160961.html?itemId=/content/journals/10.4269/ajtmh.16-0961&mimeType=html&fmt=ahah

References

  1. Richner S, Laifer G, , 2010. Peripheral lymphadenopathy in immunocompetent adults. Swiss Med Wkly 140: 98104.
  2. Pangalis G, Boussiotis V, Fessas P, , 1993. Clinical approach to a patient with lymphadenopathy. Pangalis G, Polliack A, eds. Benign and Malignant Lymphadenopathies. Clinical and Laboratory Diagnosis. London, United Kingdom: Harwood Academic Publishers, 19–29.
  3. Moore S, Schneider J, Schaaf H, , 2003. Diagnostic aspects of cervical lymphadenopathy in children in the developing world: a study of 1,877 surgical specimens. Pediatr Surg Int 19: 240244.[Crossref]
  4. Hansen R, Vedsted P, Sokolowski I, Søndergaard J, Olesen F, , 2011. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res 11: 18.[Crossref]
  5. Moore DAJ, , et al., 2006. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 355: 15391550.[Crossref]
  6. Kirwan DE, , et al., 2015. Microscopic observation drug susceptibility (MODS) for rapid diagnosis of lymph node tuberculosis and detection of drug resistance. J Clin Microbiol 54: 185189.[Crossref]
  7. Landis J, Koch G, , 1977. The measurement of observer agreement for categorical data. Biometrics 33: 159174.[Crossref]
  8. Osores F, Nolasco O, Verdonck K, Arevalo J, Ferrufino JC, Agapito J, Huayanay L, Gotuzzo E, Maguina C, , 2006. Clinical evaluation of a 16S ribosomal RNA polymerase chain reaction test for the diagnosis of lymph node tuberculosis. Clin Infect Dis 43: 855859.[Crossref]
  9. Albasri A, El-Siddiq A, Hiussainy A, Alhujaily A, , 2014. Pattern of lymph node pathology in western Saudi Arabia. Asian Pac J Cancer Prev 15: 46774681.[Crossref]
  10. Olu-Eddo A, Ohanaka C, , 2006. Peripheral lymphadenopathy in Nigerial adults. J Pak Med Assoc 56: 405408.
  11. Olu-Eddo A, Omoti C, , 2011. Diagnostic evaluation of primary cervical adenopathies in a developing country. Pan Afr Med J 10: 52.
  12. Ojo B, Bulhari M, Malami S, Abdulrahaman M, , 2005. Surgical lymph node biopsies in University of Ilorin Teaching Hospital, Ilorin, Nigeria. Niger Postgrad Med J 12: 299304.
  13. Ondounda M, Gaudong Mbethe L, Mounguengui D, Magne C, Nzenze J, , 2013. Profile of adenopathies in a tropical setting: 78 observations in Gabon. Med Sante Trop 23: 304307.
  14. Abba AA, Bamgboye AE, Afzal M, Rahmatullah RA, , 2002. Lymphadenopathy in adults. A clinicopathological analysis. Saudi Med J 23: 282286.
  15. Chau I, , et al. 2003. Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients. Br J Cancer 88: 354361.[Crossref]
  16. Al Kadah B, Popov HH, Schick B, Knobber D, , 2015. Cervical lymphadenopathy: study of 251 patients. Eur Arch Otorhinolaryngol 272: 745752.[Crossref]
  17. Park DY, Kim JY, Choi KU, Lee JS, Lee CH, Sol MY, Suh KS, , 2003. Comparison of polymerase chain reaction with histopathologic features for diagnosis of tuberculosis in formalin-fixed, paraffin-embedded histologic specimens. Arch Pathol Lab Med 127: 326330.
  18. Sridhar C, Kini U, Subhash K, , 2002. Comparative cytological study of lymph node tuberculosis in HIV-infected individuals and in patients with diabetes in a developing country. Diagn Cytopathol 26: 7580.[Crossref]
  19. Sobonya RE, Yanes J, Klotz SA, , 2014. Cavitary pulmonary coccidioidomycosis: pathologic and clinical correlates of disease. Hum Pathol 45: 153159.[Crossref]
  20. Sterling T, , 2004. The WHO/IUATD diagnostic algorithm for tuberculosis and empiric fluoroquinolone use: potential pitfalls. Int J Tuberc Lung Dis 8: 13961400.
  21. de Noronha AL, Bafica A, Nogueira L, Barral A, Barral-Netto M, , 2008. Lung granulomas from Mycobacterium tuberculosis/HIV-1 co-infected patients display decreased in situ TNF production. Pathol Res Pract 204: 155161.[Crossref]
  22. Silva AA, Mauad T, Saldiva PHN, Pires-Neto RC, Coletta RD, Graner E, Vargas PA, , 2014. Immunophenotype of Lung Granulomas in HIV and Non-HIV Associated Tuberculosis. São Paulo, Brazil: MEDICALEXPRESS 1.
  23. Lawn SD, Wilkinson RJ, Lipman MCI, Wood R, , 2008. Immune reconstitution and “unmasking” of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med 177: 680–685.
  24. Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M, , 2010. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 10: 251261.[Crossref]
  25. Eza D, , et al., 2006. Postmortem findings and opportunistic infections in HIV-positive patients from a public hospital in Peru. Pathol Res Pract 202: 767775.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.16-0961
Loading
/content/journals/10.4269/ajtmh.16-0961
Loading

Data & Media loading...

  • Received : 08 Dec 2016
  • Accepted : 30 May 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error